|
Prescription Drug Search
Strengths available for Levetiracetam :
Levetiracetam 250mg
Levetiracetam 500mg
Levetiracetam 750mg
Levetiracetam 1000mg
Strengths available for Levetiracetam drops:
Levetiracetam drops 100mg/mL
Strengths available for Levetiracetam syrup:
Levetiracetam syrup 100mg/mL
Strengths available for Levetiracetam XR:
Levetiracetam XR 500mg
Browse Alphabetically:
A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #
Information about ExpressMedsCanada.com
List of countries where we can ship Levetiracetam:
- Argentina
- Armenia
- Australia
- Austria
- Bahrain
- Barbados
- Bermuda
- Bolivia
- Bosnia and Herzegovina
- Colombia
- Czech Republic
- Denmark
- Ecuador
- Estonia
- Georgia
- Grenada
- Guatemala
- Hong Kong
- India
- Indonesia
- Iran
- Japan
- Korea, Republic of
- Lebanon
- Morocco
- Netherlands Antilles
- Portugal
- Qatar
- Russian Federation
- Serbia
- Slovenia
- South Africa
- Spain
- Sri Lanka
- Sweden
- Switzerland
- Taiwan
- Tonga
- Turkey
- United Kingdom, UK
Latest news releases on Levetiracetam:
APP Pharmaceuticals Acquires Three Products from Nexus - Marketwatch
Levetiracetam Injection (100 mg/ml, 5 mL) is therapeutically equivalent to the reference-listed drug Keppra(R). Tranexamic Acid Injection (100 mg/mL, 10 mL) is therapeutically equivalent to the reference-listed drug Cyklokapron(R). According to ...
APP Pharma acquires benztropine mesylate, levetiracetam & tranexamic acid injectables from Nexus Pharma - pharmabiz.com
APP Pharmaceuticals, LLC, a Fresenius Kabi Company, has acquired benztropine mesylate injection, levetiracetam injection and tranexamic acid injection from Nexus Pharmaceuticals, Inc. Under terms of the agreement APP takes complete ownership of these ...
Phenytoin versus Leviteracetam for Seizure Prophylaxis after Brain Injury - A Meta Analysis - BioMed Central
However, it is rapidly being replaced by a new drug Levetiracetam (LEV) as the treatment of choice. We aimed to conduct a meta-analysis to compare these two drugs in patients with brain injury. An electronic search was performed in using Pubmed ...
APP expands portfolio of injectable critical care products - News-Medical.Net
Levetiracetam Injection and Tranexamic Acid Injection. "The addition of these products broadens an already extensive portfolio of injectable APP critical care products," said John Ducker, president and chief executive officer of APP Pharmaceuticals.
